Paclitaxel-HSA interaction. Binding sites on HSA molecule

Bioorganic and Medicinal Chemistry

Volumn 12, Issue 12, 2004, Pages 3269-3275

  Trynda Lemiesz, Lilianna ^a  

^a UNIVERSITY OF WROC AW   (Poland)

Author keywords

Antibody precipitate test; Bilirubin; Circular dichroism; Fluorescence; Human serum albumin; Paclitaxel; Warfarin

Indexed keywords

BILIRUBIN; HEME; HUMAN SERUM ALBUMIN; PACLITAXEL; TRYPTOPHAN; WARFARIN;

AQUEOUS SOLUTION; ARTICLE; CIRCULAR DICHROISM; DRUG BINDING SITE; DRUG PROTEIN BINDING; DRUG STRUCTURE; FLUORESCENCE SPECTROSCOPY; PH MEASUREMENT; PRECIPITATION; PROTEIN DOMAIN; PROTEIN STABILITY; PROTEIN STRUCTURE;

ANTIGENS; BILIRUBIN; BINDING SITES; CIRCULAR DICHROISM; CISPLATIN; HEME; HUMANS; MOLECULAR STRUCTURE; PACLITAXEL; PROTEIN BINDING; SERUM ALBUMIN; SPECTROMETRY, FLUORESCENCE; TITRIMETRY; WARFARIN;

EID: 2542431258     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2004.03.073     Document Type: Article

References (31)

1. Qin M., Nilson M., Oie S. J. Pharmacol. Exp. Ther. 269:1994;117
2. Kratz F., Beyer U. Drug Delivery. 5:1998;1
3. Jain R.K. Cancer. Res. 50:1990;8145
4. Peters T. Jr. All about Albumin; Biochemistry, Genetics and Medical Applications. 1996;Academic, Orlando, FL. pp 79-126
5. Carter D.C., Ho J.X. Adv. Protein Chem. 45:1994;153
6. He X.M., Carter D.C. Nature. 358:1992;209
7. Kragh-Hansen U. Pharmacol. Rev. 33:1981;17
8. Dockal M., Carter D.C., Rukert F. J. Biol. Chem. 274:1999;29303
9. Wardell M., Wang Z., Ho J.X., Robert J., Ruuker F., Ruble J., Carter D.C. Biochem. Biophys. Res. Commun. 291:2002;813
10. Sudlow G., Birkett D.J., Wade D.N. Mol. Pharmacol. 12:1976;1052
11. Horwitz S.B., Lothsteia L., Manfredi J.J., Melade W., Parness J., Roy S.N., Shiff P.B., Sorbara L., Zeheb R. Ann. NY Acad. Sci. 466:1986;733
12. Rowinsky E.K., Cazenave L.A., Donchover R.C. J. Natl. Cancer Inst. 82:1990;1247
13. Guenard D., Gueritte-Voegelein F., Poiter P. Account. Chem. Res. 26:1993;160
14. Choy H. Crit. Rev. Oncol. Hematol. 37:2001;237
15. Khayat D., Antoine E.C., Coeffic D. Cancer. Invest. 18:2000;242
16. Ricco R., Riley C., VonHoff D., Kuhn J., Philips J., Brown T. J. Pharm. Biomed. Anal. 8:1990;159
17. Tar B.D., Yalkowsky S.H. J. Parentral Sci. 41:1987;31
18. Kramer I., Heuser A. Eur. Hosp. Pharm. 1:1995;37-41
19. Brouwer E., Verweij J., De Bruijn P., Loos W.J., Pillay M., Buijs D., Sparreboom A. Drug Metab. Dispos. 28(10):2000;1141
20. Purcell M., Neault J.F., Tajmir-Riahi H.A. Biochim. Biophys. Acta. 1478:2000;61
21. Paál K., Müller J., Hegedûs L. Eur. J. Biochem. 268:2001;2187
22. Freifelder D. Physical Biochemistry: Applications to Biochemistry and Molecular Biology. 1976;W.H. Freeman, San Francisco. pp 410-443
23. Bos O.J.M., Remijn J.P.M.J., Fisher E., Witing J., Janssen L.H.M. Biochem. Pharmacol. 37:1988;3905
24. Fehske K.J., Muller W.E., Wollert U. Mol. Pharmacol. 16:1979;778
25. Athar H., Ahmad N., Tayyab S., Qasim M.A. Int. J. Biol. Macromol. 25(4):1999;353
26. Kazim A.L., Habeeb A.F.S.A., Atassi M.Z. Mol. Immunol. 16:1979;457
27. Sakata S., Attasi M.Z. Mol. Immunol. 17:1980;139
28. Trynda L., Przywarska-Boniecka H., Kociukiewicz T. J. Inorg. Biochem. 38:1990;153
29. Trynda L., Kuduk-Jaworska J. J. Inorg. Biochem. 53:1994;249
30. Beaven G.H., Chen S.H., d'Albis A., Gratzer W.B. Eur. J. Biochem. 41:1974;539
31. Blauer G., Harmatz D., Snir J. Biochem. Biophys. Acta. 279:1972;68